"prostate cancer" trang 7 - tải miễn phí từ tailieunhanh
Can you un-ring the bell? A qualitative study of how affect influences cancer screening decisions

Can you un-ring the bell? A qualitative study of how affect influences cancer screening decisions
14    42    1
JS-K, a nitric oxide pro-drug, regulates growth and apoptosis through the ubiquitin-proteasome pathway in prostate cancer cells

JS-K, a nitric oxide pro-drug, regulates growth and apoptosis through the ubiquitin-proteasome pathway in prostate cancer cells
10    51    1
Aberrant expression of the microtubuleassociated protein tau is an independent prognostic feature in prostate cancer

Aberrant expression of the microtubuleassociated protein tau is an independent prognostic feature in prostate cancer
10    39    1
Pattern of care of prostate cancer patients across the Martinique: Results of a population-based study in the Caribbean

Pattern of care of prostate cancer patients across the Martinique: Results of a population-based study in the Caribbean
9    34    1
Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells

Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells
10    53    1
MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer

MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer
12    60    1
Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: A study protocol

Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: A study protocol
12    61    1
A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: Trends in clinical presentation and management of the disease

A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: Trends in clinical presentation and management of the disease
11    79    1
Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: A randomized controlled phase II a trial

Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: A randomized controlled phase II a trial
8    55    1
Identification of oxidized protein hydrolase as a potential prodrug target in prostate cancer

Identification of oxidized protein hydrolase as a potential prodrug target in prostate cancer
14    67    1
Enhanced detection of metastatic prostate cancer cells in human plasma with lipid bodies staining

Enhanced detection of metastatic prostate cancer cells in human plasma with lipid bodies staining
12    51    1
Survival outcomes in men with a positive family history of prostate cancer: A registry based study

Survival outcomes in men with a positive family history of prostate cancer: A registry based study
8    42    1
High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy

High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy
7    47    1
Breast and prostate cancer: an analysis of common epidemiological features in mortality trends in Spain

Breast and prostate cancer: an analysis of common epidemiological features in mortality trends in Spain
10    40    1
Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer

Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer
10    45    1
Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer

Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer
12    42    1
Time from diagnosis to surgery and prostate cancer survival: A retrospective cohort study

Time from diagnosis to surgery and prostate cancer survival: A retrospective cohort study
6    52    1
Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castrationsensitive prostate cancer patients with osteoporosis

Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castrationsensitive prostate cancer patients with osteoporosis
7    34    1
Suboptimal use of hormonal therapy among German men with localized high-risk prostate Cancer during 2005 to 2015: Analysis of registry data

Suboptimal use of hormonal therapy among German men with localized high-risk prostate Cancer during 2005 to 2015: Analysis of registry data
13    29    1
Benefit finding in men affected by prostate cancer prior to and following radical prostatectomy – a cross-sectional study with a stratified sample

Benefit finding in men affected by prostate cancer prior to and following radical prostatectomy – a cross-sectional study with a stratified sample
11    5    1